Home / Inspections / 1205970

FDA Inspection 1205970 — Alabama Center for Reproductive Medicine

Alabama Center for Reproductive Medicine — FEI 3015364206

The FDA completed an inspection of Alabama Center for Reproductive Medicine on May 18, 2023 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Birmingham, AL (United States)

Facility

Other inspections at this facility

  • 1281660 (VAI Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123194 (NAI Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123204 (NAI Wed Jan 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources